Oxybutynin Oral Syrup 5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Oxybutynin: Oral syrup (5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

OXYBUTYNIN (ox i BYOO ti nin) is used to treat overactive bladder. This medicine reduces the amount of bathroom visits. It may also help to control wetting accidents.

In-Depth Information

Oxybutynin Chloride 5mg/5ml Syrup

NDC: 548380510
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Neurogenic Bladder, Urinary Incontinence, Overactive Bladder (OAB)

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Oxybutynin Chloride 5mg/5ml Syrup

Reported Side Effects for Oxybutynin Chloride 5mg/5ml Syrup

Excessive Thirst Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
1.0-9.6%*
Severity: MODERATE
Onset: EARLY
Breathing Difficulties Incidence:
1.0-4.9%*
Severity: SEVERE
Onset: RAPID
Confusion Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: EARLY
Metallic Taste Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Belching Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Flushing Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Heartburn Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Hoarseness Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
1.0-7.9%*
Severity: MILD
Onset: EARLY
Increased Urination Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Bladder Infection Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Dry Nose Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: EARLY
Cough Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: RAPID
Joint Pain Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Stuffy Nose Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Inflamed Eye Incidence:
1.0-4.9%*
Severity: SEVERE
Onset: EARLY
Sore Throat Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Hives Incidence:
1.0-4.9%*
Severity: MILD
Onset: RAPID
Dry Eyes Incidence:
1.0-3.1%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Difficulty Swallowing Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
1.0-5.4%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
1.0-4.9%*
Severity: MILD
Onset: DELAYED
Painful Urination Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Gas Incidence:
1.0-4.9%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
1.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Retaining Urine Incidence:
1.2-6.0%*
Severity: MODERATE
Onset: EARLY
Constipation Incidence:
1.3-15.1%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
1.5-7.5%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
2.8-16.6%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
3.0-5.5%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
3.3%*
Severity: MILD
Onset: EARLY
Dry Mouth Incidence:
4.1-71.4%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.5-6.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.5-11.6%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
5.6-14.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Oxybutynin Chloride 5mg/5ml Syrup

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and Oxybutynin Chloride 5mg/5ml Syrup(Oxybutynin Chloride)
Grapefruit juice and Oxybutynin(Oxybutynin Chloride)
Grapefruit juice and grapefruit-containing foods may increase the side effects of Oxybutynin. Do not significantly increase grapefruit juice intake while taking this drug, or avoid grapefruit juice if possible. Discuss any new or worsening side effects, such as confusion, constipation, dizziness, difficulty with urination, drowsiness, dry mouth and eyes, changes in vision, palpitations, or fast heartbeat with your health care provider. Do not drive or operate machinery until you know how these drugs affect you.
Moderate Lifestyle Interaction
Alcohol and Oxybutynin Chloride 5mg/5ml Syrup(Oxybutynin Chloride)
Alcohol and Oxybutynin(Oxybutynin Chloride)
Do not drink Alcoholic beverages while taking Oxybutynin (Ditropan). You may feel drowsy or more tired if you drink alcohol-containing drinks while taking Oxybutynin. Do not drive or operate machinery while drinking Alcoholic beverages and until you know how Oxybutynin affects you. You may also notice an increase in the frequency of urination while taking Oxybutynin and drinking alcoholic beverages.
Minor Lifestyle Interaction
Caffeine-containing Foods/Beverages and Oxybutynin Chloride 5mg/5ml Syrup(Oxybutynin Chloride)
Caffeine-containing Foods/Beverages and Oxybutynin(Oxybutynin Chloride)
The intake of beverages containing caffeine may decrease the actions of Oxybutynin because Caffeine may increase urination. You may wish to limit your caffeine intake (including intake of coffee, colas, teas, or herbal supplements) while taking oxybutynin.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Oxybutynin

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.